These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 24855827
1. Anticancer effects of celecoxib through inhibiton of STAT3 phosphorylation and AKT phosphorylation in nasopharyngeal carcinoma cell lines. Liu DB, Long GX, Mei Q, Wang JF, Hu GY, Gan L, Li WW, Sun W, Liu SF, Jiang JZ, Hu GQ. Pharmazie; 2014 May; 69(5):358-61. PubMed ID: 24855827 [Abstract] [Full Text] [Related]
2. Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation. Liu DB, Hu GY, Long GX, Qiu H, Mei Q, Hu GQ. Acta Pharmacol Sin; 2012 May; 33(5):682-90. PubMed ID: 22504904 [Abstract] [Full Text] [Related]
3. Cyclooxygenase-2 inhibitor celecoxib suppresses invasion and migration of nasopharyngeal carcinoma cell lines through a decrease in matrix metalloproteinase-2 and -9 activity. Li WW, Long GX, Liu DB, Mei Q, Wang JF, Hu GY, Jiang JZ, Sun W, Gan L, Hu GQ. Pharmazie; 2014 Feb; 69(2):132-7. PubMed ID: 24640603 [Abstract] [Full Text] [Related]
4. Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling. Kim N, Kim CH, Ahn DW, Lee KS, Cho SJ, Park JH, Lee MK, Kim JS, Jung HC, Song IS. J Gastroenterol Hepatol; 2009 Mar; 24(3):480-7. PubMed ID: 18823436 [Abstract] [Full Text] [Related]
5. Celecoxib inhibits interleukin-6/interleukin-6 receptor-induced JAK2/STAT3 phosphorylation in human hepatocellular carcinoma cells. Liu Y, Liu A, Li H, Li C, Lin J. Cancer Prev Res (Phila); 2011 Aug; 4(8):1296-305. PubMed ID: 21490132 [Abstract] [Full Text] [Related]
6. Effects of celecoxib treatment over the AKT pathway in head and neck squamous cell carcinoma. Abrahão AC, Giudice FS, Sperandio FF, Pinto Junior Ddos S. J Oral Pathol Med; 2013 Nov; 42(10):793-8. PubMed ID: 23679684 [Abstract] [Full Text] [Related]
7. Celecoxib inhibits STAT3 phosphorylation and suppresses cell migration and colony forming ability in rhabdomyosarcoma cells. Reed S, Li H, Li C, Lin J. Biochem Biophys Res Commun; 2011 Apr 15; 407(3):450-5. PubMed ID: 21397587 [Abstract] [Full Text] [Related]
8. Celecoxib induces dose dependent growth inhibition in nasopharyngeal carcinoma cell lines independent of cyclooxygenase-2 expression. Chan CM, Ma BB, Wong SC, Chan AT. Biomed Pharmacother; 2005 Oct 15; 59 Suppl 2():S268-71. PubMed ID: 16507390 [Abstract] [Full Text] [Related]
9. Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis. Liu NB, Peng T, Pan C, Yao YY, Shen B, Leng J. World J Gastroenterol; 2005 Oct 28; 11(40):6281-7. PubMed ID: 16419156 [Abstract] [Full Text] [Related]
10. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt. Liu B, Shi ZL, Feng J, Tao HM. Cell Biol Int; 2008 May 28; 32(5):494-501. PubMed ID: 18078766 [Abstract] [Full Text] [Related]
11. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib. Xie H, Gao L, Chai N, Song J, Wang J, Song Z, Chen C, Pan Y, Zhao L, Sun S, Wu K, Feitelson MA, Liu J, Fan D. Mol Carcinog; 2009 Jan 28; 48(1):56-65. PubMed ID: 18506760 [Abstract] [Full Text] [Related]
12. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma]. Liu QY, Han AJ, You SY, Dong Y, Yang QX, Wu JH, Li MF. Ai Zheng; 2008 Oct 28; 27(10):1070-6. PubMed ID: 18851787 [Abstract] [Full Text] [Related]
13. Effects of cyclooxygenase 2 inhibitors on biological traits of nasopharyngeal carcinoma cells. Chen PY, Long QC. Acta Pharmacol Sin; 2004 Jul 28; 25(7):943-9. PubMed ID: 15210070 [Abstract] [Full Text] [Related]
14. Sequential treatment of HPV E6 and E7-expressing TC-1 cells with bortezomib and celecoxib promotes apoptosis through p-p38 MAPK-mediated downregulation of cyclin D1 and CDK2. Kim JE, Lee JI, Jin DH, Lee WJ, Park GB, Kim S, Kim YS, Wu TC, Hur DY, Kim D. Oncol Rep; 2014 May 28; 31(5):2429-37. PubMed ID: 24627094 [Abstract] [Full Text] [Related]
15. OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms. Zhang S, Suvannasankha A, Crean CD, White VL, Johnson A, Chen CS, Farag SS. Clin Cancer Res; 2007 Aug 15; 13(16):4750-8. PubMed ID: 17699852 [Abstract] [Full Text] [Related]
16. Synergistic apoptotic effect of celecoxib and luteolin on breast cancer cells. Jeon YW, Suh YJ. Oncol Rep; 2013 Feb 15; 29(2):819-25. PubMed ID: 23229294 [Abstract] [Full Text] [Related]
17. Involvement of mitochondrial and Akt signaling pathways in augmented apoptosis induced by a combination of low doses of celecoxib and N-(4-hydroxyphenyl) retinamide in premalignant human bronchial epithelial cells. Schroeder CP, Kadara H, Lotan D, Woo JK, Lee HY, Hong WK, Lotan R. Cancer Res; 2006 Oct 01; 66(19):9762-70. PubMed ID: 17018636 [Abstract] [Full Text] [Related]
18. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model. Sui W, Zhang Y, Wang Z, Wang Z, Jia Q, Wu L, Zhang W. Oncol Rep; 2014 May 01; 31(5):2252-60. PubMed ID: 24647425 [Abstract] [Full Text] [Related]
19. [COX-2 inhibitor celecoxib can suppress the proliferation of FLT3-ITD positive acute myeloid leukemia cells with prominent down regulation of MEK/MCL-1 expression in vitro]. Du LX, Jia YQ, Meng WT, Shi FF, Zhong XS, Ma LL, Yuan J, Zeng JS. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct 01; 21(5):1157-61. PubMed ID: 24156425 [Abstract] [Full Text] [Related]
20. Celecoxib suppresses the phosphorylation of STAT3 protein and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells. Yang MY, Lee HT, Chen CM, Shen CC, Ma HI. Int J Mol Sci; 2014 Jun 18; 15(6):11013-29. PubMed ID: 24945311 [Abstract] [Full Text] [Related] Page: [Next] [New Search]